S. Tanaka et al., Molecular analysis of plasma alpha 1.3-fucosyltransferase deficiency and development of the methods for its genotyping, EXP CLIN IM, 18(1), 2001, pp. 1-12
Four patients with mental illness were found to be deficient in plasma alph
a1,3-fucosyltransferase for the first time in Japan [Exp Clin Immunogenet 1
999;16:125-130]. Complete sequencing of FUT6 genes in these individuals rev
ealed the presence of two point mutations, i.e., G739 to A (Glu-->247 to Ly
s) and C945 to A (Tyr-->315 to stop). In addition to two reported alleles h
aving G739 to A (pf1) and G739 to A and C945 to A (pf3), a new mutated alle
le having C945 to A (pf2) was found to be present and all the individuals w
ho lack alpha1,3-fucosyltransferase activity in plasma were found to posses
s pf genes homozygously (pf/pf). In order to detect such lethal mutations i
n FUT6 genes easily, PCR-RFLP methods have also been developed and applied
for the screening of FUT6 deficiency in a large number of samples which res
ulted in the demonstration of three additional fUT6-deficient individuals.
The absence of alpha1,3-fucosylated molecules on alpha (1)-acid glycoprotei
n in plasma from all the 7 individuals was confirmed to result from the pla
sma alpha1,3-fucosyltransferase deficiency. Copyright (C) 2001 S. Karger AG
. Basel.